Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,138,884
-$40,957 QoQ
Shares Held
7,267
-5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#581
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SevenBridge Financial Group, LLC holds $35,490,451 across 9 Drug Manufacturers - General names. NVS ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,610 | $11,075,631 | |
| 2 | LLY |
ELI LILLY & Co
|
8,963 | $10,750,491 | |
| 3 | ABBV |
AbbVie Inc.
|
15,049 | $3,786,930 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,263 | $3,246,295 | |
| 5 | AMGN |
Amgen Inc
|
7,381 | $2,672,807 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,619 | $1,245,686 | |
| 7 | NVS |
Novartis AG
This page
|
7,267 | $1,138,884 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,580 | $831,317 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,138,884 | 7,267 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,179,841 | 7,724 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,086,277 | 7,879 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,010,402 | 7,879 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,120,673 | 9,261 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $1,173,661 | 10,528 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,297,434 | 13,333 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,615,225 | 14,043 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,530,149 | 14,373 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,390,300 | 14,373 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,559,885 | 15,449 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,573,635 | 15,449 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,567,838 | 15,537 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,450,380 | 15,765 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,435,281 | 15,821 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,197,309 | 15,752 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,222,895 | 14,467 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,268,426 | 14,455 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $1,296,042 | 14,817 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,234,469 | 15,095 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,410,844 | 15,463 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,315,879 | 15,394 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,453,655 | 15,394 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,338,662 | 15,394 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,355,691 | 15,522 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $1,280,778 | 15,534 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||